Torno Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Torno Capital’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-80,000	Closed	-$1.29M	–	251
2024 Q2	$1.29M	Buy	+80,000	New	+$1.44M	0.06%	85

Other funds holding INDV

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LIP

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

Torno Capital's INDV Position: Q3 2024 in Review

Torno Capital sold out of Indivior Pharmaceuticals (INDV) in Q3 2024, closing a stake of 70,500 shares — an estimated $1.14M sold.

Torno Capital first reported a position in INDV in Q2 2024 and held it in 1 quarter. The position peaked at $1.14M in Q2 2024. 103 funds tracked by Wall St. Rank hold INDV as of Q3 2024.

Torno Capital reported no remaining Indivior Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Torno Capital sold 70,500 Indivior Pharmaceuticals shares in Q3 2024, an estimated $1.14M.
Torno Capital first reported a position in Indivior Pharmaceuticals in Q2 2024 and held it in 1 quarter.
Torno Capital's Indivior Pharmaceuticals position peaked at $1.14M in Q2 2024.
103 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2024.

Based on Torno Capital's 13F filing for Q3 2024, filed 13 Nov 2024.